- Home
- BCDA vs IVDA Comparison
BCDA vs IVDA Comparison
Compare BCDA & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- IVDA
- Stock Information
- Founded
- BCDA N/A
- IVDA 2003
- Country
- BCDA United States
- IVDA United States
- Employees
- BCDA N/A
- IVDA N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- IVDA Computer Software: Prepackaged Software
- Sector
- BCDA Health Care
- IVDA Technology
- Exchange
- BCDA Nasdaq
- IVDA Nasdaq
- Market Cap
- BCDA 11.0M
- IVDA 6.7M
- IPO Year
- BCDA N/A
- IVDA N/A
- Fundamental
- Price
- BCDA $2.12
- IVDA $2.12
- Analyst Decision
- BCDA Strong Buy
- IVDA
- Analyst Count
- BCDA 1
- IVDA 0
- Target Price
- BCDA $25.00
- IVDA N/A
- AVG Volume (30 Days)
- BCDA 204.0K
- IVDA 105.5K
- Earning Date
- BCDA 08-12-2025
- IVDA 08-13-2025
- Dividend Yield
- BCDA N/A
- IVDA N/A
- EPS Growth
- BCDA N/A
- IVDA N/A
- EPS
- BCDA N/A
- IVDA N/A
- Revenue
- BCDA $3,000.00
- IVDA $7,148,449.00
- Revenue This Year
- BCDA N/A
- IVDA $340.48
- Revenue Next Year
- BCDA N/A
- IVDA N/A
- P/E Ratio
- BCDA N/A
- IVDA N/A
- Revenue Growth
- BCDA N/A
- IVDA 54.15
- 52 Week Low
- BCDA $1.63
- IVDA $1.27
- 52 Week High
- BCDA $4.66
- IVDA $8.05
- Technical
- Relative Strength Index (RSI)
- BCDA 44.60
- IVDA 52.04
- Support Level
- BCDA $1.98
- IVDA $1.76
- Resistance Level
- BCDA $2.45
- IVDA $2.20
- Average True Range (ATR)
- BCDA 0.16
- IVDA 0.17
- MACD
- BCDA -0.01
- IVDA 0.03
- Stochastic Oscillator
- BCDA 18.00
- IVDA 79.59
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).